Cargando…
Analysis on heterogeneity of hepatocellular carcinoma immune cells and a molecular risk model by integration of scRNA-seq and bulk RNA-seq
BACKGROUND: Studies have shown that hepatocellular carcinoma (HCC) heterogeneity is a main cause leading to failure of treatment. Technology of single-cell sequencing (scRNA) could more accurately reveal the essential characteristics of tumor genetics. METHODS: From the Gene Expression Omnibus (GEO)...
Autores principales: | Liu, Xiaorui, Li, Jingjing, Wang, Qingxiang, Bai, Lu, Xing, Jiyuan, Hu, Xiaobo, Li, Shuang, Li, Qinggang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606610/ https://www.ncbi.nlm.nih.gov/pubmed/36311759 http://dx.doi.org/10.3389/fimmu.2022.1012303 |
Ejemplares similares
-
Integration of scRNA-Seq and bulk RNA-Seq uncover perturbed immune cell types and pathways of Kawasaki disease
por: Cao, Naixin, et al.
Publicado: (2023) -
Evaluating the role of IDO1 macrophages in immunotherapy using scRNA-seq and bulk-seq in colorectal cancer
por: Liu, Xingwu, et al.
Publicado: (2022) -
Exploring PANoptosis in breast cancer based on scRNA-seq and bulk-seq
por: He, Puxing, et al.
Publicado: (2023) -
Delving into the Heterogeneity of Different Breast Cancer Subtypes and the Prognostic Models Utilizing scRNA-Seq and Bulk RNA-Seq
por: Xu, Jieyun, et al.
Publicado: (2022) -
Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq
por: Zhang, Pengpeng, et al.
Publicado: (2023)